Altered cytokine production in the elderly.

Immunosenescence: emerging challenges for an ageing population. Immunology (2007) 2.32

Manifestations and mechanisms of stem cell aging. J Cell Biol (2011) 1.93

How do immune cells support and shape the brain in health, disease, and aging? J Neurosci (2013) 1.51

Inflammaging as a prodrome to Alzheimer's disease. J Neuroinflammation (2008) 1.29

Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathog (2010) 1.26

Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population. Aging Dis (2011) 1.23

Effect of ageing on pulmonary inflammation, airway hyperresponsiveness and T and B cell responses in antigen-sensitized and -challenged mice. Clin Exp Allergy (2007) 1.20

Is ageing associated with a shift in the balance between Type 1 and Type 2 cytokines in humans? Clin Exp Immunol (2002) 1.19

Aging and immune function: molecular mechanisms to interventions. Antioxid Redox Signal (2011) 1.18

The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. EMBO J (2013) 1.16

Attenuated inflammatory response in aged mice brains following stroke. PLoS One (2011) 1.14

Aging and the dendritic cell system: implications for cancer. Crit Rev Oncol Hematol (2007) 1.13

Sustained CD28 expression delays multiple features of replicative senescence in human CD8 T lymphocytes. J Clin Immunol (2010) 1.10

Lipopolysaccharide impairs amyloid β efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier. J Neuroinflammation (2012) 1.09

TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases. J Clin Immunol (2009) 1.08

Modulation of T lymphocyte replicative senescence via TNF-{alpha} inhibition: role of caspase-3. J Immunol (2009) 1.07

Ewing sarcoma gene Ews regulates hematopoietic stem cell senescence. Blood (2010) 1.04

Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest (2002) 1.04

The immune system and the impact of zinc during aging. Immun Ageing (2009) 1.03

Review article: ageing and the neutrophil: no appetite for killing? Immunology (2000) 1.03

Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors. Environ Health Perspect (2001) 1.00

NK and NKT cells in aging and longevity: role of zinc and metallothioneins. J Clin Immunol (2009) 1.00

Immunosupportive therapies in aging. Clin Interv Aging (2007) 0.97

Monocyte chemotactic protein-1 (MCP-1) and growth factors called into question as markers of prolonged psychosocial stress. PLoS One (2009) 0.97

Vitamin E supplementation increases T helper 1 cytokine production in old mice infected with influenza virus. Immunology (2000) 0.96

Age-associated alteration in innate immune response in captive baboons. J Gerontol A Biol Sci Med Sci (2011) 0.94

The effect of ageing on macrophage Toll-like receptor-mediated responses in the fight against pathogens. Clin Exp Immunol (2010) 0.94

Aging per se increases the susceptibility to free fatty acid-induced insulin resistance. J Gerontol A Biol Sci Med Sci (2010) 0.93

Immunological outcomes of exercise in older adults. Clin Interv Aging (2007) 0.92

Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c mice. J Virol (2009) 0.91

Relationship between systemic cytokines and complement factor H Y402H polymorphism in patients with dry age-related macular degeneration. Am J Ophthalmol (2013) 0.91

HIV infection and aging: enhanced Interferon- and Tumor Necrosis Factor-alpha production by the CD8+ CD28- T subset. BMC Immunol (2001) 0.90

Update on transfusion solutions during surgery: review of hydroxyethyl starches 130/0.4. Int J Gen Med (2010) 0.89

Age-related Dysregulation of Inflammation and Innate Immunity: Lessons Learned from Rodent Models. Aging Dis (2011) 0.89

NK cells in healthy aging and age-associated diseases. J Biomed Biotechnol (2012) 0.88

Effects of ageing on the immunoregulation of parasitic infection. Infect Immun (2002) 0.87

Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice. Infect Immun (2005) 0.85

Neuroendocrine effects of stress on immunity in the elderly: implications for inflammatory disease. Immunol Allergy Clin North Am (2011) 0.84

Impaired interferon-gamma production in response to live bacteria and Toll-like receptor agonists in patients with ataxia telangiectasia. Clin Exp Immunol (2006) 0.84

Evaluation of systemic markers of inflammation in atomic-bomb survivors with special reference to radiation and age effects. FASEB J (2012) 0.82

Stress, ageing and their influence on functional, cellular and molecular aspects of the immune system. Age (Dordr) (2014) 0.81

Age-related differences in cell-specific cytokine production by acutely ill Malawian patients. Clin Exp Immunol (2002) 0.81

Soluble L-selectin levels in type I diabetes mellitus: a surrogate marker for disease activity? Immunology (2000) 0.80

Urinary interleukin-8 is a biomarker of stress in emergency physicians, especially with advancing age--the JOBSTRESS* randomized trial. PLoS One (2013) 0.80

Age differences in cytokine expression under conditions of health using experimental pain models. Exp Gerontol (2015) 0.79

Prenatal Dexamethasone and Postnatal High-Fat Diet Decrease Interferon Gamma Production through an Age-Dependent Histone Modification in Male Sprague-Dawley Rats. Int J Mol Sci (2016) 0.79

Aging, immunosenescence and membrane rafts: the lipid connection. Longev Healthspan (2012) 0.79

Chronic resveratrol intake reverses pro-inflammatory cytokine profile and oxidative DNA damage in ageing hybrid mice. Age (Dordr) (2010) 0.79

CD11c+ Dendritic Cells Accelerate the Rejection of Older Cardiac Transplants via Interleukin-17A. Circulation (2015) 0.79

A noninflammatory immune response in aged DNA Aβ42-immunized mice supports its safety for possible use as immunotherapy in AD patients. Neurobiol Aging (2014) 0.79

Decreased response to IL-12 and IL-18 of peripheral blood cells in rheumatoid arthritis. Arthritis Res Ther (2003) 0.79

Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms. Clin Mol Allergy (2017) 0.77

Ageing exacerbates damage of systemic and salivary neutrophils from patients presenting Candida-related denture stomatitis. Immun Ageing (2009) 0.77

Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats. Am J Neurodegener Dis (2016) 0.77

Calcium Dynamics of Ex Vivo Long-Term Cultured CD8+ T Cells Are Regulated by Changes in Redox Metabolism. PLoS One (2016) 0.76

Elevated levels of interferon-γ production by memory T cells do not promote transplant tolerance resistance in aged recipients. PLoS One (2013) 0.75

Retracted Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease. Am J Neurodegener Dis (2016) 0.75

Sepsis and Immunosenescence in the Elderly Patient: A Review. Front Med (Lausanne) (2017) 0.75

Inflammation & autoimmunity in human ageing: dendritic cells take a center stage. Indian J Med Res (2013) 0.75

Changes of peripheral lymphocyte subsets and cytokine environment during aging and deteriorating gastrointestinal tract health status. Oncotarget (2017) 0.75

Human T cell immunosenescence and inflammation in aging. J Leukoc Biol (2017) 0.75

Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature (1982) 3.26

Antiviral effects of recombinant tumour necrosis factor in vitro. Nature (1986) 3.25

The immunobiology of zinc. Immunol Today (1997) 2.93

High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis (1998) 2.48

Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology (2000) 2.46

Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus. J Exp Med (1974) 2.40

Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum. J Immunol (1975) 2.13

Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). J Clin Oncol (2004) 2.07

Interferon-gamma production by Listeria monocytogenes-specific T cells active in cellular antibacterial immunity. Eur J Immunol (1983) 2.06

Home therapy with recombinant interleukin-2 and interferon-alpha 2b in advanced human malignancies. Lancet (1990) 1.80

Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst (1996) 1.79

Low ferritin levels indicate the need for iron supplementation: strategy to minimize iron-depletion in regular blood donors. Transfus Med (2000) 1.67

Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction. J Clin Microbiol (1992) 1.66

Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice. J Immunol (1975) 1.62

Failure to detect human cytomegalovirus DNA in peripheral blood leukocytes of healthy blood donors by the polymerase chain reaction. Transfusion (1992) 1.60

Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma. J Clin Oncol (1995) 1.58

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand (1988) 1.57

Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription. Virology (1988) 1.55

Interleukin-2 based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patients. J Urol (1996) 1.55

Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors. J Immunol (1976) 1.53

Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2. Ann Oncol (1992) 1.50

Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virus in vitro. J Immunol (1979) 1.46

Production of immune interferon by murine T-cell clones from long-term cultures. Nature (1981) 1.45

IL-2 in combination with IFN- alpha and 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial. Br J Cancer (2001) 1.42

Production of cytokines in acute schizophrenic psychosis. Biol Psychiatry (1996) 1.41

[An interuniversity comparison of the supervision of doctoral candidates--should the promotion procedures be changed?]. Dtsch Med Wochenschr (2000) 1.40

Coincidence of neonatal alloimmune thrombocytopenia and maternal anti-D immunization: case report. Br J Haematol (1998) 1.37

The detection of human cytomegalovirus immediate early antigen in peripheral blood leucocytes. J Immunol Methods (1991) 1.35

The influence of naturally occurring heterophilic anti-immunoglobulin antibodies on direct measurement of serum proteins using sandwich ELISAs. J Immunol Methods (2000) 1.34

Kinetics of the Zn 2+ - stimulation of human peripheral lmphocytes in vitro. Proc Soc Exp Biol Med (1971) 1.34

Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes. J Immunol (1985) 1.28

Genetic variability of herpes simplex virus: development of a pathogenic variant during passaging of a nonpathogenic herpes simplex virus type 1 virus strain in mouse brain. J Virol (1983) 1.27

Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2',5'-adenylate synthetase. J Gen Virol (1988) 1.26

Experimental infection of inbred mice with herpes simplex virus type 1. I. Investigation of humoral and cellular immunity and of interferon induction. J Gen Virol (1981) 1.25

Failure to detect antiviral activity in serum and plasma of healthy individuals displaying high activity in ELISA for IFN-alpha and IFN-beta. J Interferon Cytokine Res (1999) 1.24

Replication of herpes simplex virus in human T lymphocytes: characterization of the viral target cell. J Immunol (1984) 1.24

In vitro mitogenic stimulation of murine spleen cells by herpes simplex virus. J Immunol (1978) 1.24

Zinc-altered immune function and cytokine production. J Nutr (2000) 1.22

The effects of general anesthesia on human peripheral immune cell distribution and cytokine production. Clin Immunol Immunopathol (1997) 1.21

Prostaglandin synthesis in spleen cell cultures of mice injected with Corynebacterium parvum. Cell Immunol (1978) 1.20

Interaction of Bartonella henselae with endothelial cells results in rapid bacterial rRNA synthesis and replication. Cell Microbiol (2000) 1.19

Human cytomegalovirus replicates in primary human bone marrow cells. J Gen Virol (1986) 1.18

Cytokine production and serum proteins in depression. Scand J Immunol (1995) 1.18

Experimental infection of inbred mice with herpes simplex virus. V. Investigations with a virus strain non-lethal after peripheral infection. J Gen Virol (1982) 1.18

Pokeweed mitogen-, concanavalin A-, and phytohemagglutinin-induced development of cytotoxic effector lymphocytes. An evaluation of the mechanisms of T cell-mediated cytotoxicity. J Exp Med (1973) 1.16

Rapid HLA-DRB1 genotyping by nested PCR amplification. Tissue Antigens (1992) 1.16

The role of interferon in the resistance of C57BL/6 mice to various doses of herpes simplex virus type 1. J Infect Dis (1982) 1.16

Inhibition of the mixed lymphocyte culture by peritoneal exudate cells. Cell Immunol (1976) 1.15

Stimulation of chicken lymphocytes in a serum-free medium. Cell Immunol (1972) 1.15

Mycoplasma contamination in human tumor cell lines: effect on interferon induction and susceptibility to natural killing. J Immunol (1981) 1.13

Dysregulation between TH1 and TH2 T cell subpopulations in the elderly. Mech Ageing Dev (1996) 1.08

A reappraisal of the effector cells mediating mitogen induced cellular cytotoxicity. Cell Immunol (1975) 1.08

Clonal analysis of human T cell activation by the Mycoplasma arthritidis mitogen (MAS). Eur J Immunol (1988) 1.08

An X-linked locus influences the amount of circulating interferon induced in the mouse by herpes simplex virus type 1. J Gen Virol (1982) 1.08

Inflammatory markers in major depression and melancholia. J Affect Disord (2001) 1.07

Cytomegalovirus transcripts in peripheral blood leukocytes of actively infected transplant patients detected by reverse transcription-polymerase chain reaction. J Infect Dis (1993) 1.07

Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial. Ann Oncol (2008) 1.06

Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology. Mol Psychiatry (2001) 1.05

Inhibition of in vitro lymphoproliferative responses to tumor-associated antigens by suppressor cells from rats bearing progressively growing Gross leukemia virus-induced tumors. Int J Cancer (1975) 1.05

Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders. J Clin Microbiol (2001) 1.05

Kinetics and organ distribution of allogeneic natural killer lymphocytes transfused into patients suffering from renal cell carcinoma. Stem Cells Dev (2004) 1.04

Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients. Transplantation (1995) 1.04

Protection against herpes simplex virus infection in mice by Corynebacterium parvum. Infect Immun (1977) 1.04

Stimulation of human peripheral lymphocytes by Zn2+ in vitro. Exp Cell Res (1970) 1.04

Recent progress in the tumor necrosis factor-alpha field. Int Arch Allergy Immunol (1996) 1.03

Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma. Br J Cancer (1999) 1.03

A whole-blood technique for testing production of human interferon by leukocytes. J Immunol Methods (1982) 1.03

Human peripheral null lymphocytes. II. Producers of type-1 interferon upon stimulation with tumor cells, Herpes simplex virus and Corynebacterium parvum. Eur J Immunol (1980) 1.02

Experimental infection of inbred mice with herpes simplex virus. II. Interferon production and activation of natural killer cells in the peritoneal exudate. J Gen Virol (1981) 1.02

Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease. Eur J Gastroenterol Hepatol (1999) 1.02

Production of an antiviral factor by murine spleen cells after treatment with Corynebacterium parvum. Cell Immunol (1977) 1.02

Production of immune interferon is regulated by more than T cell subset: Lyt-1,2,3 and Qat-5 phenotypes of murine T lymphocytes involved in IFN-gamma production in primary and secondary mixed lymphocyte reaction. Eur J Immunol (1982) 1.02

Extracellular and immunological actions of zinc. Biometals (2002) 1.02

Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Transfusion (2000) 1.02

Cytokine production after helium-neon laser irradiation in cultures of human peripheral blood mononuclear cells. J Photochem Photobiol B (1992) 1.01

Biochemotherapy of advanced metastatic renal-cell carcinoma: results of the combination of interleukin-2, alpha-interferon, 5-fluorouracil, vinblastine, and 13-cis-retinoic acid. World J Urol (1995) 1.01

Elevated plasma levels of S-100b protein in schizophrenic patients. Biol Psychiatry (1999) 1.01

A human whole-blood assay for analysis of T-cell function by quantification of cytokine mRNA. Scand J Immunol (1999) 1.01

Immunobiology of human papillomavirus infection. Prog Med Virol (1986) 1.00

The production of a monocyte chemotactic factor by agammaglobulinemic chicken spleen cells. J Immunol (1972) 1.00

Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancer. J Clin Oncol (1999) 1.00

Production of colony-stimulating factors by Hodgkin cell lines. Int J Cancer (1983) 1.00

alpha-Interferon and interleukin-2 in renal cell carcinoma: studies in nonhospitalized patients. Semin Oncol (1991) 0.99

Induction of cytokines and cytotoxicity against tumor cells by Newcastle disease virus. Cancer Biother (1994) 0.99

Experimental infection of inbred mice with herpes simplex virus. III. Comparison between newborn and adult C57BL/6 mice. J Gen Virol (1982) 0.99

Protection of mice by an apathogenic strain HSV-1 against lethal infection by a pathogenic strain of HSV-1. J Gen Virol (1981) 0.99

Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. Eur Arch Psychiatry Clin Neurosci (1996) 0.98

Protection of mice against viral infection by Corynebacterium parvum and Bordetella pertussis. J Gen Virol (1978) 0.98

Interferon production in cocultures between mouse spleen cells and tumor cells: possible role of mycoplasmas in interferon induction. J Immunol Methods (1980) 0.98

The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB6 and GL183) in individuals with different HLA phenotypes. Immunology (1997) 0.97

Cytokine production of neutrophils is limited to interleukin-8. Immunology (1996) 0.97

Biochemical characterization of the T-cell mitogen derived from Mycoplasma arthritidis. Scand J Immunol (1986) 0.97

Interferon production in the murine mixed lymphocyte culture. I. Interferon production caused by differences in the H-2 K and H-2 D region but not by differences in the I region or the M locus. Eur J Immunol (1979) 0.97

Low prevalence of diphtheria antitoxin in children and adults in northern Germany. Eur J Clin Microbiol Infect Dis (1995) 0.97

Different effects of IFN gamma and IFN alpha/beta on "immediate early" gene expression of HSV-1. Virology (1990) 0.96

Decrease of natural killer cell activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factor. Blood (1988) 0.96

Suppression of cell-mediated tumour immunity by Corynebacterium parvum. Nature (1975) 0.96

Cancer, cytokines, and cytotoxic cells: interleukin-2 in the immunotherapy of human neoplasms. Klin Wochenschr (1990) 0.96

Lymphocyte activation and induction of interferon gamma in human leucocyte cultures by the mitogen in Mycoplasma arthritidis supernatant (MAS). Scand J Immunol (1986) 0.96

Suppression of in vitro lymphocyte stimulation in mice bearing primary Moloney sarcoma virus-induced tumors. Cell Immunol (1974) 0.96